These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 18336331)

  • 1. Synthesis and pharmacological profile of a series of 1-substituted-2-carbonyl derivatives of Diphenidol: novel M4 muscarinic receptor antagonists.
    Varoli L; Angeli P; Buccioni M; Burnelli S; Fazio N; Marucci G; Recanatini M; Spampinato S
    Med Chem; 2008 Mar; 4(2):121-8. PubMed ID: 18336331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diphenidol-related diamines as novel muscarinic M4 receptor antagonists.
    Varoli L; Andreani A; Burnelli S; Granaiola M; Leoni A; Locatelli A; Morigi R; Rambaldi M; Bedini A; Fazio N; Spampinato S
    Bioorg Med Chem Lett; 2008 May; 18(9):2972-6. PubMed ID: 18395442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and antagonistic activity at muscarinic receptor subtypes of some 2-carbonyl derivatives of diphenidol.
    Varoli L; Angeli P; Burnelli S; Marucci G; Recanatini M
    Bioorg Med Chem; 1999 Sep; 7(9):1837-44. PubMed ID: 10530931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and antagonistic activity at muscarinic receptor subtypes of some derivatives of diphenidol.
    Varoli L; Angeli P; Buccioni M; Burnelli S; Cavalli A; Marucci G; Recanatini M
    Farmaco; 2003 Sep; 58(9):651-7. PubMed ID: 13679157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and pharmacology of benzoxazines as highly selective antagonists at M(4) muscarinic receptors.
    Böhme TM; Augelli-Szafran CE; Hallak H; Pugsley T; Serpa K; Schwarz RD
    J Med Chem; 2002 Jul; 45(14):3094-102. PubMed ID: 12086495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-activity relationships of dimethindene derivatives as new M2-selective muscarinic receptor antagonists.
    Böhme TM; Keim C; Kreutzmann K; Linder M; Dingermann T; Dannhardt G; Mutschler E; Lambrecht G
    J Med Chem; 2003 Feb; 46(5):856-67. PubMed ID: 12593665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of PCS1055, a novel muscarinic M4 receptor antagonist.
    Croy CH; Chan WY; Castetter AM; Watt ML; Quets AT; Felder CC
    Eur J Pharmacol; 2016 Jul; 782():70-6. PubMed ID: 27085897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological properties of TD-6301, a novel bladder selective muscarinic receptor antagonist.
    McNamara A; Pulido-Rios MT; Sweazey S; Obedencio GP; Thibodeaux H; Renner T; Armstrong SR; Steinfeld T; Hughes AD; Wilson RD; Jasper JR; Mammen M; Hegde SS
    Eur J Pharmacol; 2009 Mar; 605(1-3):145-52. PubMed ID: 19168050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Muscarinic subtype affinity and functional activity profile of 1-methyl-2-(2-methyl-1,3-dioxolan-4-yl)pyrrolidine and 1-methyl-2-(2-methyl-1,3-oxathiolan-5-yl)pyrrolidine derivatives.
    Dei S; Angeli P; Bellucci C; Buccioni M; Gualtieri F; Marucci G; Manetti D; Matucci R; Romanelli MN; Scapecchi S; Teodori E
    Biochem Pharmacol; 2005 Jun; 69(11):1637-45. PubMed ID: 15896343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis, affinity profile and functional activity of potent chiral muscarinic antagonists with a pyrrolidinylfuran structure.
    Scapecchi S; Nesi M; Matucci R; Bellucci C; Buccioni M; Dei S; Guandalini L; Manetti D; Martelli C; Martini E; Marucci G; Orlandi F; Romanelli MN; Teodori E; Cirilli R
    J Med Chem; 2010 Jan; 53(1):201-7. PubMed ID: 19928767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclohexylmethylpiperidinyltriphenylpropioamide: a selective muscarinic M(3) antagonist discriminating against the other receptor subtypes.
    Sagara Y; Sagara T; Mase T; Kimura T; Numazawa T; Fujikawa T; Noguchi K; Ohtake N
    J Med Chem; 2002 Feb; 45(4):984-7. PubMed ID: 11831911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A potent, long-acting, orally active (2R)-2-[(1R)-3, 3-difluorocyclopentyl]-2-hydroxy-2-phenylacetamide: novel muscarinic M(3) receptor antagonist with high selectivity for M(3) over M(2) receptors.
    Mitsuya M; Kobayashi K; Kawakami K; Satoh A; Ogino Y; Kakikawa T; Ohtake N; Kimura T; Hirose H; Sato A; Numazawa T; Hasegawa T; Noguchi K; Mase T
    J Med Chem; 2000 Dec; 43(26):5017-29. PubMed ID: 11150173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective antagonism activity of alkaloids from bulbs Fritillariae at muscarinic receptors: functional studies.
    Lin BQ; Ji H; Li P; Jiang Y; Fang W
    Eur J Pharmacol; 2006 Dec; 551(1-3):125-30. PubMed ID: 17027747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of the muscarinic receptor subtype mediating inhibition of the neurogenic contractions in rabbit isolated vas deferens by a series of polymethylene tetra-amines.
    Budriesi R; Cacciaguerra S; Toro RD; Bolognesi ML; Chiarini A; Minarini A; Rosini M; Spampinato S; Tumiatti V; Melchiorre C
    Br J Pharmacol; 2001 Mar; 132(5):1009-16. PubMed ID: 11226131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis, affinity profile, and functional activity of muscarinic antagonists with a 1-methyl-2-(2,2-alkylaryl-1,3-oxathiolan-5-yl)pyrrolidine structure.
    Dei S; Bellucci C; Buccioni M; Ferraroni M; Guandalini L; Manetti D; Martini E; Marucci G; Matucci R; Nesi M; Romanelli MN; Scapecchi S; Teodori E
    J Med Chem; 2007 Mar; 50(6):1409-13. PubMed ID: 17305327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis of new cardioselective M2 muscarinic receptor antagonists.
    Mandelli GR; Maiorana S; Terni P; Lamperti G; Colibretti ML; Imbimbo BP
    Chem Pharm Bull (Tokyo); 2000 Nov; 48(11):1611-22. PubMed ID: 11086886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis, muscarinic blocking activity and molecular modeling studies of 4-DAMP-related compounds.
    Recanatini M; Tumiatti V; Budriesi R; Chiarini A; Sabatino P; Bolognesi ML; Melchiorre C
    Bioorg Med Chem; 1995 Mar; 3(3):267-77. PubMed ID: 7606388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel oxotremorine-related heterocyclic derivatives: Synthesis and in vitro pharmacology at the muscarinic receptor subtypes.
    Dallanoce C; De Amici M; Barocelli E; Bertoni S; Roth BL; Ernsberger P; De Micheli C
    Bioorg Med Chem; 2007 Dec; 15(24):7626-37. PubMed ID: 17889543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological characterization of muscarinic receptors implicated in rabbit detrusor muscle contraction and activation of inositol phospholipid hydrolysis in rabbit detrusor and parotid gland.
    Barras M; Coste A; Eon MT; Guillot E
    Fundam Clin Pharmacol; 1999; 13(5):562-70. PubMed ID: 10520729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel imidazole derivatives with subtype-selective antimuscarinic activity (2).
    Miyachi H; Kiyota H; Segawa M
    Bioorg Med Chem Lett; 1998 Aug; 8(16):2163-8. PubMed ID: 9873506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.